MAZE THERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-11: Form 10-Q; Exhibit 10.1; Description Non-Employee Director Compensation Policy, as amended June 1, 2026..
- 2026-03-25: Form 10-K; Exhibit 10.19; Description Loan and Security Agreement, dated February 4, 2026, by and between Maze Therapeutics, Inc. and Hercules Capital, Inc..
- 2025-11-06: Form 10-Q; Exhibit 10.3; Description Offer Letter by and between Maze Therapeutics, Inc. and Misbah Tahir..
- 2025-09-11: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-11 | 10-Q | 10.1 | Non-Employee Director Compensation Policy, as amended June 1, 2026. |
|---|
| 2026-03-25 | 10-K | 10.19 | Loan and Security Agreement, dated February 4, 2026, by and between Maze Therapeutics, Inc. and Hercules Capital, Inc. |
|---|
| 2025-11-06 | 10-Q | 10.3 | Offer Letter by and between Maze Therapeutics, Inc. and Misbah Tahir. |
|---|
| 2025-09-11 | 8-K | 10.2 | Form of Registration Rights Agreement. |
|---|
| 2025-09-11 | 8-K | 10.1 | Form of Securities Purchase Agreement. |
|---|
| 2025-03-31 | 10-K | 10.17 | Second Amendment to the Loan and Security Agreement, dated March 28, 2025, by and between Maze Therapeutics, Inc. and Banc of California. |
|---|